The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
AMP-activated protein kinase: a potential target for the diseases prevention by natural occurring polyphenols
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Feige, J. N., Lagouge, M., Canto, C., Strehle, A., Houten, S. M., Milne, J. C., Lambert, P. D., Mataki, C., Elliott, P. J., & Auwerx, J. (2008) · Cell Metabolism · doi:10.1016/j.cmet.2008.08.017 · Cited by 719
Exercise training‐induced improvements in insulin action
Hawley, J. A., & Lessard, S. J. (2008) · Acta Physiologica · doi:10.1111/j.1748-1716.2007.01783.x · Cited by 454
Concurrent regulation of AMP-activated protein kinase and SIRT1 in mammalian cells
Suchankova, G., Nelson, L. E., Gerhart-Hines, Z., Kelly, M., Gauthier, M.-S., Saha, A. K., Ido, Y., Puigserver, P., & Ruderman, N. B. (2009) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2008.11.130 · Cited by 162
Research works printed but not linked: 72
- Hardie, 2007, AMP-activated/SNF1 protein kinases: conserved guardians of cellular energy, Nat. Rev. Mol. Cell Biol., 8, 774, 10.1038/nrm2249 · DOI · Paper page
- Hawley, 2003, Complexes between the LKB1 tumor suppressor, STRAD alpha/beta and MO25 alpha/beta are upstream kinases in the AMP-activated protein kinase cascade, J. Biol., 2, 28, 10.1186/1475-4924-2-28 · DOI · Paper page
- Day, 2007, Structure of a CBS-domain pair from the regulatory gamma1 subunit of human AMPK in complex with AMP and ZMP, Acta. Crystallogr. D. Biol. Crystallogr., 63, 587, 10.1107/S0907444907009110 · DOI
- Wong, 2006, A revised model for AMP-activated protein kinase structure: the alpha-subunit binds to both the beta- and gamma-subunits although there is no direct binding between the beta- and gamma-subunits, J. Biol. Chem., 281, 36434, 10.1074/jbc.M607410200 · DOI
- Carling, 2005, AMP-activated protein kinase: balancing the scales, Biochimie, 87, 87, 10.1016/j.biochi.2004.10.017 · DOI · Paper page
- Hardie, 2004, The AMP-activated protein kinase pathway—new players upstream and downstream, J. Cell Sci., 117, 5479, 10.1242/jcs.01540 · DOI · Paper page
- Young, 2005, AMP-activated protein kinase: a key stress signaling pathway in the heart, Trends Cardiovasc. Med., 15, 110, 10.1016/j.tcm.2005.04.005 · DOI · Paper page
- Hue, 2003, New targets of AMP-activated protein kinase, Biochem. Soc. Trans., 31, 213, 10.1042/bst0310213 · DOI
- Hardie, 2005, New roles for the LKB1→AMPK pathway, Curr. Opin. Cell Biol., 17, 167, 10.1016/j.ceb.2005.01.006 · DOI · Paper page
- Rattan, 2005, 5-Aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside inhibits cancer cell proliferation in vitro and in vivo via AMP-activated protein kinase, J. Biol. Chem., 280, 39582, 10.1074/jbc.M507443200 · DOI · Paper page
- Xiang, 2004, AMP-activated protein kinase activators can inhibit the growth of prostate cancer cells by multiple mechanisms, Biochem. Biophys. Res. Commun., 321, 161, 10.1016/j.bbrc.2004.06.133 · DOI · Paper page
- Guan, 2007, AICAR inhibits proliferation and induced S-phase arrest, and promotes apoptosis in CaSki cells, Acta. Pharmacol. Sin., 28, 1984, 10.1111/j.1745-7254.2007.00675.x · DOI
- Viollet, 2007, Targeting AMP-activated protein kinase as a novel therapeutic approach for the treatment of metabolic disorders, Diabetes Metab., 33, 395, 10.1016/j.diabet.2007.10.004 · DOI · Paper page
- Steinberg, 2007, The AMP-activated protein kinase: role in regulation of skeletal muscle metabolism and insulin sensitivity, Mini Rev. Med. Chem., 7, 519, 10.2174/138955707780619662 · DOI
- Cartee, 2007, Role of Akt substrate of 160kDa in insulin-stimulated and contraction-stimulated glucose transport, Appl. Physiol. Nutr. Metab., 32, 557, 10.1139/H07-026 · DOI · Paper page
- Tomas, 2002, Hyperglycemia and insulin resistance: possible mechanisms, Ann. N. Y. Acad. Sci., 967, 43, 10.1111/j.1749-6632.2002.tb04262.x · DOI · Paper page
- Sarbassov, 2005, Growing roles for the mTOR pathway, Curr. Opin. Cell Biol., 17, 596, 10.1016/j.ceb.2005.09.009 · DOI · Paper page
- Dray, 2008, Apelin stimulates glucose utilization in normal and obese insulin-resistant mice, Cell Metab., 8, 437, 10.1016/j.cmet.2008.10.003 · DOI · Paper page
- Saha, 2003, Malonyl-CoA and AMP-activated protein kinase: an expanding partnership, Mol. Cell Biochem., 253, 65, 10.1023/A:1026053302036 · DOI · Paper page
- Hardie, 2002, Regulation of fatty acid synthesis and oxidation by the AMP-activated protein kinase, Biochem. Soc. Trans., 30, 1064, 10.1042/bst0301064 · DOI · Paper page
- Kim, 2008, Anti-obesity effects of Juniperus chinensis extract are associated with increased AMP-activated protein kinase expression and phosphorylation in the visceral adipose tissue of rats, Biol. Pharm. Bull., 31, 1415, 10.1248/bpb.31.1415 · DOI
- Ching, 1996, Analysis of the specificity of the AMP-activated protein kinase by site-directed mutagenesis of bacterially expressed 3-hydroxy 3-methylglutaryl-CoA reductase, using a single primer variant of the unique-site-elimination method, Eur. J. Biochem., 237, 800, 10.1111/j.1432-1033.1996.0800p.x · DOI
- Pallottini, 2004, Mechanisms underlying the impaired regulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase in aged rat liver, Mech. Ageing Dev., 125, 633, 10.1016/j.mad.2004.08.001 · DOI
- Hadad, 2008, Targeting AMPK: a new therapeutic opportunity in breast cancer, Crit. Rev. Oncol. Hematol., 67, 1, 10.1016/j.critrevonc.2008.01.007 · DOI
- Rosner, 2008, The tuberous sclerosis gene products hamartin and tuberin are multifunctional proteins with a wide spectrum of interacting partners, Mutat. Res., 658, 234, 10.1016/j.mrrev.2008.01.001 · DOI
- Motoshima, 2006, AMPK and cell proliferation—AMPK as a therapeutic target for atherosclerosis and cancer, J. Physiol., 574, 63, 10.1113/jphysiol.2006.108324 · DOI · Paper page
- Dolinsky, 2006, Role of AMP-activated protein kinase in healthy and diseased hearts, Am. J. Physiol. Heart Circ. Physiol., 291, H2557, 10.1152/ajpheart.00329.2006 · DOI
- Davies, 2006, Characterization of the role of gamma2 R531G mutation in AMP-activated protein kinase in cardiac hypertrophy and Wolff-Parkinson-White syndrome, Am. J. Physiol. Heart Circ. Physiol., 290, H1942, 10.1152/ajpheart.01020.2005 · DOI
- Schwartz, 2007, Tuberous sclerosis complex: advances in diagnosis, genetics, and management, J. Am. Acad. Dermatol., 57, 189, 10.1016/j.jaad.2007.05.004 · DOI · Paper page
- Rosner, 2008, The mTOR pathway and its role in human genetic diseases, Mutat. Res., 659, 284, 10.1016/j.mrrev.2008.06.001 · DOI · Paper page
- Cheng, 2004, Thr2446 is a novel mammalian target of rapamycin (mTOR) phosphorylation site regulated by nutrient status, J. Biol. Chem., 279, 5719, 10.1074/jbc.C300534200 · DOI · Paper page
- Pedersen, 2007, IL-6 signalling in exercise and disease, Biochem. Soc. Trans., 35, 1295, 10.1042/BST0351295 · DOI · Paper page
- Carey, 2006, Interleukin-6 increases insulin-stimulated glucose disposal in humans and glucose uptake and fatty acid oxidation in vitro via AMP-activated protein kinase, Diabetes, 55, 2688, 10.2337/db05-1404 · DOI · Paper page
- Watt, 2006, CNTF reverses obesity-induced insulin resistance by activating skeletal muscle AMPK, Nat. Med., 12, 541, 10.1038/nm1383 · DOI · Paper page
- Hwang, 2007, Apoptotic effect of EGCG in HT-29 colon cancer cells via AMPK signal pathway, Cancer Lett., 247, 115, 10.1016/j.canlet.2006.03.030 · DOI · Paper page
- Collins, 2007, Epigallocatechin-3-gallate (EGCG), a green tea polyphenol, suppresses hepatic gluconeogenesis through 5′-AMP-activated protein kinase, J. Biol. Chem., 282, 30143, 10.1074/jbc.M702390200 · DOI · Paper page
- Jung, 2008, Epigallocatechin gallate stimulates glucose uptake through the phosphatidylinositol 3-kinase-mediated pathway in L6 rat skeletal muscle cells, J. Med. Food, 11, 429, 10.1089/jmf.2007.0107 · DOI
- Hwang, 2005, Genistein, EGCG, and capsaicin inhibit adipocyte differentiation process via activating AMP-activated protein kinase, Biochem. Biophys. Res. Commun., 338, 694, 10.1016/j.bbrc.2005.09.195 · DOI · Paper page
- Fan, 2008, Molecular mechanism of apoptosis induction by resveratrol, a natural cancer chemopreventive agent, Int. J. Vitam. Nutr. Res., 78, 3, 10.1024/0300-9831.78.1.3 · doi:10.1024/0300-9831.78.1.3
- Jiang, 2008, Sirtuins: novel targets for metabolic disease in drug development, Biochem. Biophys. Res. Commun., 373, 341, 10.1016/j.bbrc.2008.06.048 · DOI
- Tian, 2006, Inhibition of fatty acid synthase by polyphenols, Curr. Med. Chem., 13, 967, 10.2174/092986706776361012 · DOI
- Breen, 2008, Stimulation of muscle cell glucose uptake by resveratrol through sirtuins and AMPK, Biochem. Biophys. Res. Commun., 374, 117, 10.1016/j.bbrc.2008.06.104 · DOI · Paper page
- Park, 2007, Resveratrol stimulates glucose transport in C2C12 myotubes by activating AMP-activated protein kinase, Exp. Mol. Med., 39, 222, 10.1038/emm.2007.25 · DOI · Paper page
- Penumathsa, 2008, Resveratrol enhances GLUT-4 translocation to the caveolar lipid raft fractions through AMPK/AKT/eNOS signaling pathway in diabetic myocardium, J. Cell Mol. Med., 10.1111/j.1582-4934.2008.00251.x · DOI · Paper page
- Zang, 2006, Polyphenols stimulate AMP-activated protein kinase, lower lipids, and inhibit accelerated atherosclerosis in diabetic LDL receptor-deficient mice, Diabetes, 55, 2180, 10.2337/db05-1188 · DOI · Paper page
- Palasciano, 2007, Non-alcoholic fatty liver disease in the metabolic syndrome, Curr. Pharm. Des., 13, 2193, 10.2174/138161207781039652 · DOI
- Shang, 2008, Resveratrol improves non-alcoholic fatty liver disease by activating AMP-activated protein kinase, Acta. Pharmacol. Sin., 29, 698, 10.1111/j.1745-7254.2008.00807.x · DOI · Paper page
- Ajmo, 2008, Resveratrol alleviates alcoholic fatty liver in mice, Am. J. Physiol. Gastrointest. Liver Physiol., 295, G833, 10.1152/ajpgi.90358.2008 · DOI · Paper page
- Gerhauser, 2008, Cancer chemopreventive potential of apples, apple juice, and apple components, Planta Med., 74, 1608, 10.1055/s-0028-1088300 · DOI · Paper page
- Ahn, 2008, The anti-obesity effect of quercetin is mediated by the AMPK and MAPK signaling pathways, Biochem. Biophys. Res. Commun., 373, 545, 10.1016/j.bbrc.2008.06.077 · DOI · Paper page
- Fang, 2008, Kaempferol and quercetin isolated from Euonymus alatus improve glucose uptake of 3T3-L1 cells without adipogenesis activity, Life Sci., 82, 11, 10.1016/j.lfs.2007.12.021 · DOI · Paper page
- Lee, 2005, Radioprotective potential of ginseng, Mutagenesis, 20, 237, 10.1093/mutage/gei041 · DOI · Paper page
- Hwang, 2007, Anti-obesity effects of ginsenoside Rh2 are associated with the activation of AMPK signaling pathway in 3T3-L1 adipocyte, Biochem. Biophys. Res. Commun., 364, 1002, 10.1016/j.bbrc.2007.10.125 · DOI · Paper page
- Xie, 2005, Anti-diabetic effect of ginsenoside Re in ob/ob mice, Biochim. Biophys. Acta, 1740, 319, 10.1016/j.bbadis.2004.10.010 · DOI
- Park, 2005, Inhibitory effect of ginsenoside Rb1 and compound K on NO and prostaglandin E2 biosyntheses of RAW264.7 cells induced by lipopolysaccharide, Biol. Pharm. Bull., 28, 652, 10.1248/bpb.28.652 · DOI · Paper page
- Park, 2008, 20(S)-ginsenoside Rg3 enhances glucose-stimulated insulin secretion and activates AMPK, Biol. Pharm. Bull., 31, 748, 10.1248/bpb.31.748 · DOI
- Ferguson, 2007, Cancer prevention by dietary bioactive components that target the immune response, Curr. Cancer Drug Targets, 7, 459, 10.2174/156800907781386605 · DOI
- Menon, 2007, Antioxidant and anti-inflammatory properties of curcumin, Adv. Exp. Med. Biol., 595, 105, 10.1007/978-0-387-46401-5_3 · DOI · Paper page
- Pan, 2008, AMPK mediates curcumin-induced cell death in CaOV3 ovarian cancer cells, Oncol. Rep., 20, 1553
- Lee, 2009, Curcumin exerts antidifferentiation effect through AMPKalpha-PPAR-gamma in 3T3-L1 adipocytes and antiproliferatory effect through AMPKalpha-COX-2 in cancer cells, J. Agric. Food Chem., 57, 305, 10.1021/jf802737z · DOI · Paper page
- Lee, 2007, CAPE (caffeic acid phenethyl ester) stimulates glucose uptake through AMPK (AMP-activated protein kinase) activation in skeletal muscle cells, Biochem. Biophys. Res. Commun., 361, 854, 10.1016/j.bbrc.2007.07.068 · DOI
- Arayne, 2007, The berberis story: Berberis vulgaris in therapeutics, Pak. J. Pharm. Sci., 20, 83
- Yin, 2008, Traditional chinese medicine in treatment of metabolic syndrome, Endocr. Metab. Immune. Disord. Drug Targets, 8, 99, 10.2174/187153008784534330 · DOI · Paper page
- Serafim, 2008, Different concentrations of berberine result in distinct cellular localization patterns and cell cycle effects in a melanoma cell line, Cancer Chemother. Pharmacol., 61, 1007, 10.1007/s00280-007-0558-9 · DOI
- Park, 2006, Synthesis of 13-(substituted benzyl) berberine and berberrubine derivatives as antifungal agents, Bioorg. Med. Chem. Lett., 16, 3913, 10.1016/j.bmcl.2006.05.033 · DOI
- Liang, 2008, Berberine inhibits platelet-derived growth factor-induced growth and migration partly through an AMPK-dependent pathway in vascular smooth muscle cells, Eur. J. Pharmacol., 590, 343, 10.1016/j.ejphar.2008.06.034 · DOI
- Kim, 2007, Berberine activates GLUT1-mediated glucose uptake in 3T3-L1 adipocytes, Biol. Pharm. Bull., 30, 2120, 10.1248/bpb.30.2120 · DOI
- Cheng, 2006, Berberine-stimulated glucose uptake in L6 myotubes involves both AMPK and p38 MAPK, Biochim. Biophys. Acta, 1760, 1682, 10.1016/j.bbagen.2006.09.007 · DOI · Paper page
- Lee, 2006, Berberine, a natural plant product, activates AMP-activated protein kinase with beneficial metabolic effects in diabetic and insulin-resistant states, Diabetes, 55, 2256, 10.2337/db06-0006 · DOI · Paper page
- Brusq, 2006, Inhibition of lipid synthesis through activation of AMP kinase: an additional mechanism for the hypolipidemic effects of berberine, J. Lipid Res., 47, 1281, 10.1194/jlr.M600020-JLR200 · DOI · Paper page
- Lin, 2007, Theaflavins attenuate hepatic lipid accumulation through activating AMPK in human HepG2 cells, J. Lipid Res., 48, 2334, 10.1194/jlr.M700128-JLR200 · DOI · Paper page
- Park, 2008, Resveratrol downregulates Acetyl-CoA carboxylase α and fatty acid synthase by AMPK-mediated downregulation of mTOR in breast cancer cells, Food Sci. Biotechnol., 17, 1047
Cited by
Impact of Dietary Polyphenols on Carbohydrate Metabolism
Hanhineva, K., Törrönen, R., Bondia-Pons, I., Pekkinen, J., Kolehmainen, M., Mykkänen, H., & Poutanen, K. (2010) · International Journal of Molecular Sciences · doi:10.3390/ijms11041365 · Cited by 1,157
Salminen, A., Hyttinen, J. M. T., & Kaarniranta, K. (2011) · Journal of Molecular Medicine · doi:10.1007/s00109-011-0748-0 · Cited by 866
AMP-Activated Protein Kinase (AMPK) Controls the Aging Process via an Integrated Signaling Network
Salminen, A., & Kaarniranta, K. (2012) · Ageing Research Reviews · doi:10.1016/j.arr.2011.12.005 · Cited by 860
The flavonoid quercetin in disease prevention and therapy: Facts and fancies
Russo, M., Spagnuolo, C., Tedesco, I., Bilotto, S., & Russo, G. L. (2012) · Biochemical Pharmacology · doi:10.1016/j.bcp.2011.08.010 · Cited by 698
AMPK: A Target for Drugs and Natural Products With Effects on Both Diabetes and Cancer
Hardie, D. G. (2013) · Diabetes · doi:10.2337/db13-0368 · Cited by 458
Metadata
- Authors
- Hwang, J.-T., Kwon, D. Y., & Yoon, S. H.
- Venue
- New Biotechnology
- Publisher
- Elsevier BV
- Published
- 2009-10
- Volume
- 26
- Issue
- 1-2
- Pages
- 17-22
- ISSN
- 1871-6784 (ISSN-L)
- OpenAlex
- W2043498277
- Cited by
- 221
- References
- 3
- FWCI
- 7.08
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- Funders
- Korea Science and Engineering Foundation
- Ministry of Science and Technology, Pakistan
- Korea Research Council for Industrial Science and Technology
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: AMP-activated protein kinase: a potential target for the diseases prevention by natural occurring polyphenols. https://app.cochat.ai/papers/10.1016/j.nbt.2009.03.005
- The paper
- Hwang, J.-T., Kwon, D. Y., & Yoon, S. H. (2009). AMP-activated protein kinase: a potential target for the diseases prevention by natural occurring polyphenols. New Biotechnology. https://doi.org/10.1016/j.nbt.2009.03.005
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.